Hims & Hers, the leading health and wellness platform, announced a first-of-its-kind intelligent care experience that puts AI directly inside customers’ care, not on the sidelines of it. Rolling out first to Hers weight loss members, this proactive care experience delivers personalized gui...
Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, announced a collaboration and co-exclusive licensing agreement with AstraZeneca. Under this agreement, the companies will advance AZD4241, a preclinical investigational therapy for patients with est...
Hippocratic AI has announced the immediate availability of its climate-responsive voice AI agents for health systems and payers across the US, enabling healthcare organisations to conduct rapid outreach to vulnerable patients during heatwaves, wildfire smoke events, extreme cold and other weather-re...
ICON plc announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON’s digital innovation and AI strategy, and builds on Orbis – ICON’s secure, governed, agentic AI platform...
The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic researchers, pharmaceutical companies, and philanthropic organisations of which Washington University School of Medicine in St. Louis is a founding member, ...
Enterprise software is entering a new era where conversations, rather than clicks, are becoming the primary interface for getting work done. Powered by advances in generative AI, large language models, and real-time speech intelligence, voice-first AI is enabling organisations to automate customer i...
Clinical-stage biotech Alchemab Therapeutics has extended its Series A financing with a £25 million ($34 million) investment from the British Business Bank – the Bank’s largest investment in a life sciences company to date. The funding will enable the company to build its...
Altasciences, a fully integrated early-phase drug development organisation, and Evidence Matters, a pioneer in clinical trial data science, announced a successful proof-of-concept (POC) of RegulatoryFlow (RegFlow), following the announcement of the companies’ strategic collaboration in&nb...
MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, announced the launch of two breakthrough innovations that close the gap between digital intelligence and physical execution in biology: ProtoPilot, a self-evolving multi-agent system driven by r...
NVIDIA has announced the integration of its BioNeMo Agent Toolkit with Anthropic's newly launched Claude Science, enabling researchers to use natural language to perform complex scientific workflows across genomics, drug discovery, protein engineering and molecular design.
The collaboration marks a...
ScribeEMR and SlicedHealth, have announced a strategic partnership to offer complementary AI and RCM solutions to help hospitals, health systems, and community health providers bolster their revenue cycle management capabilities, reduce denials and leverage AI documentation.
ScribeEMR provides AI-p...
Infosys, a global leader in AI–first business consulting and technology services, announced its strategic collaboration with Sentara, a leading not–for–profit healthcare organization, to create a scalable foundation for AI–driven transformation that aims to enhance ...
Oracle Health and Theator are working together to provide AI-powered surgical intelligence solutions to Oracle Health customers in the U.S. With Theator's solutions, which capture surgical video footage and use AI to analyze it and cross-reference EHR data, surgical teams can benefit ...
NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life sciences era.
Including more than a decade’s worth of NVIDIA life sciences libraries, tools and open models, the toolkit enables AI agents, scientists and labs to work together ...
ChemT Biotechnology, an AI-driven biotechnology company building the intelligence layer for biomanufacturing, has closed a US$4 million seed round led by Wavemaker Ventures, the early-stage fund of Wavemaker Partners, with participation from co-investment partner SEEDS, an arm of SG Growth Capital, ...
Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. to accelerate AI-enabled drug discovery using Greenstone’s large-scale, human biobank of induced pluripotent stem cells and Intel’s Edge AI advanced computing and AI infr...
SimplePractice, the leading platform powering independent mental health practitioners, announced Care Aide, an AI-powered clinical workflow assistant designed to help independent practitioners reduce administrative burden and stay focused on care. Developed with input from more than 1,000 menta...
The National Council on Ageing (NCOA), the national voice for every person's right to age well, has released a new research series examining the promises and risks of using Artificial Intelligence (AI) in home- and community-based care that helps older Americans and individuals with d...
